Proton Therapy in the Treatment of Anal Cancer in Pelvic Kidney Transplant Recipients: A Case Series

被引：6

作者：

Buchberger, David ^{[1
]}

Kreinbrink, Paul ^{[1
]}

Kharofa, Jordan ^{[1
]}

机构：

[1] Univ Cincinnati, Dept Radiat Oncol, Med Ctr, 234 Goodman St,ML 0757, Cincinnati, OH 45267 USA

来源：

INTERNATIONAL JOURNAL OF PARTICLE THERAPY | 2019年 / 6卷 / 01期

关键词：

intensity-modulated proton therapy; anal cancer; anal neoplasia; kidney transplant; pelvic kidney; RENAL-TRANSPLANTATION; RANDOMIZED-TRIAL; CARCINOMA; ORGAN; CHEMORADIATION; RADIOTHERAPY; MITOMYCIN; RISK; 5-FLUOROURACIL; CHEMOTHERAPY;

D O I：

10.14338/IJPT-19-00067.1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: The incidence of anal cancer in patients with kidney transplants has increased. The definitive treatment for anal cancer is chemotherapy and intensity-modulated radiation therapy. In kidney transplant recipients, sparing the pelvic kidney in the process of delivering radiation to the anus can be challenging. Intensity-modulated proton therapy (IMPT) has been proposed as an alternative to intensity-modulated radiation therapy for the treatment of anal cancer in this population, given its increased ability to spare organs-at-risk. Case Series: We present 4 cases of patients with transplanted pelvic kidneys who subsequently developed anal cancer and were treated with IMPT from 2017 to 2019. Conclusion: Use of IMPT appears to be an acceptable option for the treatment of anal cancer in patients with a pelvic kidney.

引用

页码：28 / 34

页数：7

共 50 条

[41] Treating cancer in kidney transplant recipients
Maria Chiara Masone
Nature Reviews Urology, 2022, 19 : 514 - 514
[42] Pelvic Organ Prolapse Management in Female Kidney Transplant Recipients
Hoda, M. Raschid
Wagner, Sigrid
Greco, Francesco
Heynemann, Hans
Fornara, Paolo
JOURNAL OF UROLOGY, 2010, 184 (03): : 1064 - 1068
[43] Monoclonal Antibody Therapy for SARS-CoV-2 Infection in Kidney Transplant Recipients: A Case Series From Belgium
Fernandes, Guillaume
Devresse, Arnaud
Scohy, Anais
Yombi, Jean Cyr
Belkhir, Leila
De Greef, Julien
Darius, Tom
Buemi, Antoine
Kabamba, Benoit
Goffin, Eric
Kanaan, Nada
TRANSPLANTATION, 2022, 106 (01) : E107 - E108
[44] Evaluation of Filgrastim Therapy in Kidney Transplant Recipients
Poon, Teresa
Guerra, Christina M.
PROGRESS IN TRANSPLANTATION, 2017, 27 (04) : 360 - 364
[45] Immunosuppressive Therapy for Elderly Kidney Transplant Recipients
Iwamoto, H.
Nakamura, Y.
Konno, O.
Tomita, K.
Ueno, T.
Yokoyama, T.
Kihara, Y.
Kawachi, S.
TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 799 - 801
[46] Brincidofovir for Disseminated Adenovirus in Kidney and Kidney-Pancreas Transplant Recipients: Report of a Case Series.
Bowman, L.
Baliga, R.
Mayer, C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 534 - 535
[47] Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer
Anand, Aman
Bues, Martin
Rule, William G.
Keole, Sameer R.
Beltran, Chris J.
Yin, Jun
Haddock, Michael G.
Hallemeier, Christopher L.
Miller, Robert C.
Ashman, Jonathan B.
RADIOTHERAPY AND ONCOLOGY, 2015, 117 (03) : 505 - 508
[48] ANTIBODY MEDIATED REJECTION THERAPY WITH BORTEZOMIB IN LUNG TRANSPLANT RECIPIENTS: A CASE SERIES
Andreas, Fiene
Paul, Robinson
Adrian, Havryk
Rebecca, Pearson
Monique, Malouf
Allan, Glanville
IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A26 - A26
[49] Oral Papillomatosis in Immunocompromised Patients: A Case Series of Kidney Transplant Recipients and Myelodysplastic Syndrome
Kwak, Eun-Jung
Choi, Yun Hee
Park, Wonse
Cho, Eunae Sandra
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2018, 76 (01) : 128 - 133
[50] Outcomes of kidney transplant recipients with ESKD due to plasma cell dyscrasia: A case series
Dinh, Alex R.
Wong, Sandy W.
Martin, Thomas G.
Wolf, Jeffrey L.
Webber, Allison B.
CLINICAL TRANSPLANTATION, 2022, 36 (03)

← 1 2 3 4 5 →